13 hasil untuk "Kenneth Hess"
Menampilkan 1–13 · 0,59 detik · RSS
-
Artikel Jurnal
An Empirical Study of Univariate and Genetic Algorithm-Based Feature Selection in Binary Classification with Microarray Data
Background We consider both univariate- and multivariate-based feature selection for the problem of binary classification with microarray data. The idea is to determine whether the more sophisticated multivariate approach leads to better misclassification error rates because of the potential to…
Juga tersedia di: DOAJ
-
Artikel Jurnal
Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy
Abstract Background Patients with breast cancer who have a pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) have improved survival. We hypothesize that once pCR has been achieved, there is no difference in subsequent postsurgical recurrence-free survival (RFS), whichever NACT…
-
Artikel Jurnal
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials
Abstract Background Immunotherapies, specifically those based on immune checkpoint inhibitors, have shown promising activity in multiple tumor types. Other than mifamurtide (MEPACT®) for osteosarcoma approved by European Medicines Agency, there are no approved immunotherapies for sarcomas. Methods…
-
Artikel Jurnal Teks lengkap
FBXW7 Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors
Purpose: FBXW7 is a tumor suppressor gene responsible for the degradation of several proto-oncogenes. Preclinical data suggest that FBXW7 mutations sensitize cells to mTOR inhibitors. Clinicopathologic characteristics of cancer patients with FBXW7 mutations and their responses to mTOR inhibitors…
Juga tersedia di: DOAJ
-
Artikel Jurnal
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
Background In this phase I/II trial, we evaluated the safety and effectiveness of pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from metastatic non-small cell lung cancer (mNSCLC).Methods Patients with lung or liver lesions amenable to RT plus at least one…
-
Artikel Jurnal
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
Abstract Background Adrenocortical carcinoma (ACC) is a rare malignancy without good treatment options. There are limited data about the use of immunotherapy in ACC. We investigated the efficacy and safety of pembrolizumab in patients with metastatic ACC. Methods This is a pre-specified cohort of a…
-
Artikel Jurnal Teks lengkap
A Crowdsourcing Approach to Developing and Assessing Prediction Algorithms for AML Prognosis
Acute Myeloid Leukemia (AML) is a fatal hematological cancer. The genetic abnormalities underlying AML are extremely heterogeneous among patients, making prognosis and treatment selection very difficult. While clinical proteomics data has the potential to improve prognosis accuracy, thus far, the…
Juga tersedia di: DOAJ
-
Artikel Jurnal
Formation of nanoscale vapour films governing thermal resistance in amorphous ice
Abstract Among the many anomalous properties of water, the formation of amorphous ice is one of its most intriguing phenomena. When water vapour is deposited at very low temperatures, it forms an amorphous solid known as amorphous solid water (ASW). Here, we combine X-ray free-electron laser…
-
Artikel Jurnal
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
Purpose The receptor tyrosine kinase rearranged during transfection (RET) can be oncogenically activated by gene fusions or point mutations. Multikinase inhibitors such as cabozantinib, lenvatinib and vandetanib have demonstrated activity in RET-dependent malignancies, and selective RET inhibitors…
-
Artikel Jurnal
Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory
Introduction Immunotherapies have revolutionized the treatment of various cancers, but little is known about their symptomatic toxicity. Assessing these symptoms is best accomplished by asking the patients themselves. However, such reports are subjective and may face challenges as bonafide…